Aarti Pharmalabs Approves Grant of 850 Stock Options Under PSOP 2023
Aarti Pharmalabs Ltd 路 Others (Uncategorized) 路 29 Oct 2026, 1:23 am
Aarti Pharmalabs Approves Grant of 850 Stock Options Under PSOP 2023 Aarti Pharmalabs Limited's Nomination and Remuneration Committee approved the grant of 850 stock options to eligible employees under the APL Performance Stock Option Plan 2023 (PSOP 2023) at its meeting on 28th Oct'26. The options are granted at an exercise price of Rs. 5 per option, compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Original exchange filing (PDF)
More announcements from Aarti Pharmalabs Ltd
- Intimation of sad demise of Promoter and Chairman Emeritus of the Company 路 16 Nov 2026
- Q2 FY 27 Earnings Call Transcript 路 04 Nov 2026
- Audio Recording of Conference Call for Investor and Analysts 路 30 Oct 2026
- Q2 FY 2027 Investor Presentation 路 29 Oct 2026
- Please find enclosed 路 29 Oct 2026
- Please find enclosed 路 29 Oct 2026
- Please find enclosed 路 29 Oct 2026
- Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 29 Oct 2026
